Pharmaceutical Knowledge, Evidence-Based

India's drug regulator grants breakthrough approval for a domestically developed mRNA vaccine platform targeting dengue and chikungunya.

As paracetamol-related liver injuries rise in India, experts debate whether the world's most popular analgesic needs stricter regulatory controls.

An analysis of India's evolving biosimilar regulations, market dynamics, and the country's position as a global biosimilar hub.

A patient-friendly guide to antibiotic resistance — why it happens, how to prevent it, and what India is doing to combat this growing threat.

An evidence-based comparison of two first-line oral hypoglycemic agents, examining efficacy, safety profiles, and patient outcomes in the Indian population.

A deep dive into the molecular modifications that give semaglutide its remarkably long half-life, enabling convenient once-weekly dosing for diabetes and obesity.